Showing results (491-500 of 1,382) with videos related to
Sort By:
Pageof 139
Schweizerische Medizinische Wochenschrift|March 7, 1992
[Acquired hemoglobin H disease in the early stage of erythroleukemia]W Bürgi, P Schlup, K A Deubelbeiss, et al.Protein Science : a Publication of the Protein Society|August 1, 1992
Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substratesJ Stürzebecher, U Neumann, U Kohnert, et al.Studies in Health Technology and Informatics|March 23, 2007
Validation system of MR image overlay and other needle insertion techniquesGregory S Fischer, Eva Dyer, Csaba Csoma, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Alpha-adrenoceptor mediated facilitation of acetylcholine release in the rat perfused heartI T Bognar, R Baretti, S Fischer, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 1979
Properties of a membrane-bound phosphatase activity in normal and abnormal red blood cellsJ Delaunay, S Fischer, J P Piau, et al.The American Journal of Medicine|September 18, 1987
Effects of short-term insulin therapy upon therapeutic response to glipizideS L Schwartz, J S Fischer, M S Kipnes, et al.Diabetes Care|September 1, 1997
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDMS M Haffner, M Hanefeld, S Fischer, et al.Methods in Molecular Biology (Clifton, N.J.)|August 25, 2021
Methods for Quantitative Assessment of Protein DegradationRadosław P Nowak, Hong Yue, Emily Y Park, et al.Biochimica Et Biophysica Acta|March 14, 1980
Endogenous phosphorylation of soluble enzymes in human red cells. Cyclic 3',5'-AMP-dependent phosphorylation of phosphofructokinase without detectable regulatory effectJ L Lagrange, J Marie, D Cottreau, et al.Journal of General Internal Medicine|September 6, 2002
Advance care planningRuss C Kolarik, Robert M Arnold, Gary S Fischer, et al.Pageof 139